NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Craig D, Fayter D, Stirk L, et al. Growth Monitoring for Short Stature: Update of a Systematic Review and Economic Model. Southampton (UK): NIHR Journals Library; 2011 Feb. (Health Technology Assessment, No. 15.11.)

Cover of Growth Monitoring for Short Stature: Update of a Systematic Review and Economic Model

Growth Monitoring for Short Stature: Update of a Systematic Review and Economic Model.

Show details

References

1.
Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon JP, Craen M, et al. Trends in age at diagnosis of Turner syndrome. Arch Dis Child. 2005;90:267–8. [PMC free article: PMC1720288] [PubMed: 15723912]
2.
Fayter D, Nixon J, Hartley S, Rithalia A, Butler G, Rudolf M, et al. A systematic review of the routine monitoring of growth in children of primary school age to identify growth-related conditions. Health Technol Assess. 2007;11(22) [PubMed: 17580001]
3.
Oostdijk W, Grote FK, de Muinck Keizer-Schrama SMPF, Wit JM. Diagnostic approach in children with short stature. Horm Res. 2009;72:206–17. [PubMed: 19786792]
4.
Thomas M, Massa G, Craen M, De Zegher F, Bourguignon JP, Heinrichs C, et al. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986–2001. Eur J Endocrinol. 2004;151:67–72. [PubMed: 15248824]
5.
Harris M, Hofman PL, Cutfield WS. Growth hormone treatment in children: review of safety and efficacy. Pediatr Drugs. 2004;6:93–106. [PubMed: 15035650]
6.
Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006;91:3897–902. [PubMed: 16849410]
7.
van Rijn JC, Grote FK, Oostdijk W, Wit JM. Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms. Arch Dis Child. 2004;89:882–3. [PMC free article: PMC1763207] [PubMed: 15321874]
8.
Prader-Willi Syndrome Association (UK) Prader–Willi Syndrome Association (UK) website. [17 March 2010]. URL: http://pwsa​.co.uk/main.php.
9.
National Institute for Health and Clinical Excellence. Growth failure (in children) – human growth hormone (HGH) (review) [9 March 2010]. URL: www​.nice.org.uk/guidance/index​.jsp?action​=byId&o=11712.
10.
Bondy CA. Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis. 2008;3:2–15. [PubMed: 18373744]
11.
Hulse JA, Schilg S. United Kingdom community growth screening 1994: a survey of current practice. J Med Screen. 1995;2:154–6. [PubMed: 8536186]
12.
Department of Health. National Child Measurement Programme. [10 March 2010]. URL: www​.dh.gov.uk/en/Publichealth​/Healthimprovement​/Healthyliving/DH_100123.
13.
The Health and Social Care Information Centre. National Child Measurement Programme: England, 2008/9 school year. [10 March 2010]. URL: www​.ic.nhs.uk/statistics-and-data-collections​/health-and-lifestyles​/obesity/national-child-measurement-programme-england-2008-09-school-year.
14.
Grote F. PhD thesis. Leiden: Leiden University; 2007. Assessment of short stature in children: auxological screening and diagnostic work-up.
15.
Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 1995;73:17–24. [PMC free article: PMC1511167] [PubMed: 7639543]
16.
National Screening Committee. National Screening Committee policy – growth screening. [10 March 2010]. URL: www​.library.nhs.uk/screening​/ViewResource.aspx?resID=60315.
17.
Grote FK, Oostdijk W, de Muinck Keizer-Schrama SMPF, Dekker FW, Verkerk PH, Wit JM. Growth monitoring and diagnostic work-up of short stature: an international inventorization. J Pediatr Endocrinol Metab. 2005;18:1031–8. [PubMed: 16459448]
18.
Grote FK, van Dommelen P, Oostdijk W, de Muinck Keizer-Schrama SMPF, Verkerk PH, Wit JM, et al. Developing evidence-based guidelines for referral for short stature. Arch Dis Child. 2008;93:212–17. [PubMed: 17908714]
19.
Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. York: Centre for Reviews and Dissemination; 2009.
20.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet. 1999;354:1896–900. [PubMed: 10584742]
21.
Anthony D, Stevens A. Growth hormone in children (for growth hormone defiency, Turner's syndrome, chronic renal failure and idiopathic short stature) Bristol: NHS Executive South West; 1996.
22.
Busschbach JJ, Rikken B, Grobbee OE, De Charro FT, Wit JM, et al. Quality of life in short adults. Horm Res. 1998;49:32–8. [PubMed: 9438783]
23.
National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2008.
24.
Grote FK, Oostdijk W, Keizer-Schrama S, van Dommelen P, van Buuren S, Dekker FW, et al. The diagnostic work up of growth failure in secondary health care; an evaluation of consensus guidelines. BMC Pediatr. 2008;8:21. [PMC free article: PMC2422838] [PubMed: 18477383]
25.
Li H, Banerjee S, Dunfield L, Kirby J, Jones M, Hamilton J, et al. Recombinant human growth hormone for treatment of Turner Syndrome: systematic review and economic evaluation. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH); 2007.
26.
Sutton EJ, McInerney-Leo A, Bondy CA, Gollust SE, King D, Biesecker B. Turner syndrome: four challenges across the lifespan. Am J Med Genet. 2005;139A:57–66. [PMC free article: PMC2600710] [PubMed: 16252273]
27.
Carel JC, Ecosse E, Bastie-Sigeac I, Cabrol S, Tauber M, Leger J, et al. Quality of life determinants in young women with Turner's syndrome after growth hormone treatment: results of the StaTur population-based cohort study. J Clin Endocrinol Metab. 2005;90:1992–7. [PubMed: 15644402]
28.
Carel JC, Elie C, Ecosse E, Tauber M, Leger J, Cabrol S, et al. Self-esteem and social adjustment in young women with Turner syndrome – influence of pubertal management and sexuality: population-based cohort study. J Clin Endocrinol Metab. 2006;91:2972–9. [PubMed: 16720662]
29.
Bannink EMN, Raat H, Mulder PGH, Keizer-Schrama S. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. J Pediatr. 2006;148:95–101. [PubMed: 16423606]
30.
Lagrou K, Froidecoeur C, Verlinde F, Craen M, De Schepper J, Francois I, et al. Psychosocial functioning, self-perception and body image and their auxologic correlates in growth hormone and oestrogen-treated young adult women with Turner syndrome. Horm Res. 2006;66:277–84. [PubMed: 16946621]
31.
Kilic BG, Ergur AT, Ocal G. Depression, levels of anxiety and self-concept in girls with Turner's syndrome. J Pediatr Endocrinol Metab. 2005;18:1111–17. [PubMed: 16459458]
32.
Hoybye C, Jonsson P, Monson JP, Koltowska-Haggstrom M, Hana V, Geffner M, et al. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency. Eur J Endocrinol. 2007;157:589–96. [PubMed: 17984238]
33.
Attanasio AF, Shavrikova EP, Blum WF, Shalet SM. Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. J Clin Endocrinol Metab. 2005;90:4525–9. [PubMed: 15899956]
34.
Sheppard L, Eiser C, Davies HA, Carney S, Clarke SA, Urquhart T, et al. The effects of growth hormone treatment on health-related quality of life in children. Horm Res. 2006;65:243–9. [PubMed: 16582566]
35.
Sandberg DE. Health-related quality of life as a primary endpoint for growth hormone therapy. Horm Res. 2006;65:250–2. [PubMed: 16582567]
36.
Bertella L, Mori I, Grugni G, Pignatti R, Ceriani F, Molinari E, et al. Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study. J Intellect Disabil Res. 2007;51:302–11. [PubMed: 17326811]
37.
Tanaka T, Tai S, Morisaki Y, Tachibana K, Kambayashi Y, Chihara K, et al. Evaluation of quality of life in children with GH deficiency and idiopathic short stature using the child behavior checklist. J Clin Res Pediatr Endocrinol. 2009;18:15–22. [PMC free article: PMC4004879] [PubMed: 24790375]
38.
Brutt AL, Sandberg DE, Chaplin J, Wollmann H, Noeker M, Koltowska-Haggstrom M, et al. Assessment of health-related quality of life and patient satisfaction in children and adolescents with growth hormone deficiency or idiopathic short stature – Part 1: A critical evaluation of available tools. Horm Res. 2009;72:65–73. [PubMed: 19690423]
39.
Bullinger M, Koltowska-Haggstrom M, Sandberg D, Chaplin J, Wollmann H, Noeker M, et al. Health-related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature – Part 2: Available results and future directions. Horm Res. 2009;72:74–81. [PubMed: 19690424]
40.
Visser-van Balen H, Geenen R, Moerbeek M, Stroop R, Kamp GA, Huisman J, et al. Psychosocial functioning of adolescents with idiopathic short stature or persistent short stature born small for gestational age during three years of combined growth hormone and gonadotropin-releasing hormone agonist treatment. Horm Res. 2005;64:77–87. [PubMed: 16113582]
41.
Visser-van Balen H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G. Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatr. 2007;96:715–19. [PubMed: 17381474]
42.
Bannink EMN, van Pareren YK, Theunissen NCM, Raat H, Mulder PGM, Hokken-Koelega ACS. Quality of life in adolescents born small for gestational age: does growth hormone make a difference? Horm Res. 2005;64:166–74. [PubMed: 16205095]
43.
Storch EA, Lewin AB, Silverstein JH, Baumeister A, Strawser MS, Geffken GR. Psychological adjustment of children with short stature: a comparison of clinic-referred children with short stature and type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2005;18:395–401. [PubMed: 15844474]
44.
Norrby U, Nordholm L, Andersson-Gare B, Fasth A. Health-related quality of life in children diagnosed with asthma, diabetes, juvenile chronic arthritis or short stature. Acta Paediatr. 2006;95:450–6. [PubMed: 16720493]
45.
Zlotkin D, Varma SK. Psychosocial effects of short stature. Indian J Pediatr. 2006;73:79–80. [PubMed: 16444067]
46.
Voss LD. Is short stature a problem? The psychological view. Eur J Endocrinol. 2006;155:S39–S45.
47.
Christensen TL, Djurhuus CB, Clayton P, Christiansen JS. An evaluation of the relationship between adult height and health-related quality of life in the general UK population. Clin Endocrinol. 2007;67:407–12. [PubMed: 17573903]
48.
Sandberg DE, Colsman M. Growth hormone treatment of short stature: status of the quality of life rationale. Horm Res. 2005;63:275–83. [PubMed: 15983441]
49.
Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, et al. Continuing positive secular growth change in the Netherlands. Pediatr Res. 2000;47:316–23. [PubMed: 10709729]
50.
Fredriks AM, van Buuren S, Wit JM, Verloove-Vanhorick SP. Body index measurements in 1996–7 compared with 1980. Arch Dis Child. 2000;82:107–12. [PMC free article: PMC1718204] [PubMed: 10648362]
51.
Fredriks AM, van Buuren S, Jeurissen SE, Dekker FW, Verloove-Vanhorick SP, Wit JM. Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands. Eur J Pediatr. 2003;162:788–93. [PubMed: 12942320]
52.
Fredriks AM, van Buuren S, Jeurissen SE, Dekker FW, Verloove-Vanhorick SP, Wit JM. Height, weight, body mass index and pubertal development references for children of Moroccan origin in the Netherlands. Acta Paediatr. 2003;93:817–24. [PubMed: 15244233]
53.
Department of Health. NHS reference costs 2008–2009. 2009. [15 February 2010]. URL: www​.dh.gov.uk/en/Publicationsandstatistics​/Publications/PublicationsPolicyAndGuidance/DH_111591.
54.
Curtis L, Netten A. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent; 2009.
55.
Takeda A, Cooper K, Bird A, Baxter L, Frampton GK, Gospodarevskaya E, et al. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technol Assess. 2010;14(42) [PubMed: 20849734]
56.
Bryant J, Baxter L, Cave CB, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev. 2007;3:CD004440. [PubMed: 17636758] [Cross Ref]
57.
van Buuren S, van Dommelen P, Zandwijken GR, Grote FK, Wit JM, Verkerk PH. Towards evidence based referral criteria for growth monitoring. Arch Dis Child. 2004;89:336–41. [PMC free article: PMC1719884] [PubMed: 15033842]
58.
Damen GM, Boersma B, Wit JM, Heymans HS. Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr. 1994;19:394–400. [PubMed: 7876992]
59.
Boersma B, Houwen RH, Blum WF, van Doorn J, Wit JM. Catch-up growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth. Horm Res. 2002;58:57–65. [PubMed: 12373016]
60.
Rongen-Westerlaken C, Corel L, van den Broeck J, Massa G, Karlberg J, Albertsson-Wikland K, et al. Reference values for height, height velocity and weight in Turner's Syndrome. Acta Paediatrica. 1997;86:937–42. [PubMed: 9343271]
61.
De Muinck Keizer-Schrama SM. [Consensus diagnosis of short stature in children. National Organization for Quality Assurance in Hospitals]. Ned Tijdschr Geneeskd. 1998;142:2519–25. [PubMed: 10028341]
© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK100735
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (706K)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to pubmed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...